Capital Guardian Trust’s Enovis ENOV Stock Holding History

Capital Guardian Trust’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-537	Closed	-$33K	–	320
2018 Q3	$33K	Buy	+537	New	+$30.6K	﹤0.01%	375

Other funds holding ENOV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCP

BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Capital Guardian Trust's ENOV Position: Q4 2018 in Review

Capital Guardian Trust sold out of Enovis (ENOV) in Q4 2018, closing a stake of 537 shares — an estimated $33K sold.

Capital Guardian Trust first reported a position in ENOV in Q3 2018 and held it in 1 quarter. The position peaked at $33K in Q3 2018. 213 funds tracked by Wall St. Rank hold ENOV as of Q4 2018.

Capital Guardian Trust reported no remaining Enovis position as of Q4 2018 after selling out during the quarter.
Capital Guardian Trust sold 537 Enovis shares in Q4 2018, an estimated $33K.
Capital Guardian Trust first reported a position in Enovis in Q3 2018 and held it in 1 quarter.
Capital Guardian Trust's Enovis position peaked at $33K in Q3 2018.
213 funds tracked by Wall St. Rank held Enovis as of Q4 2018.

Based on Capital Guardian Trust's 13F filing for Q4 2018, filed 14 Feb 2019.